Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Astellas is Exclusive Health Sponsor of the 'Ticket2Health' Initiative Promoting a Game Plan for Better Health and Wellness NORTHBROOK, Ill., Feb. 20, 2015 /PRNewswire/ -- Astellas Pharma US,...
NORTHBROOK, Ill., Feb. 19, 2015 /PRNewswire/ -- Astellas announces organizational and personnel changes in the Americas, highlighting the Company's focus on international markets, while also...
NORTHBROOK, Ill., Feb. 13, 2015 /PRNewswire/ -- Astellas Pharma Inc. (hereafter called Astellas or "the Company") President and CEO, Yoshihiko Hatanaka, announces the newest element of its...
NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration's (FDA) Anti-infective Drugs Advisory Committee voted unanimously to recommend...
NORTHBROOK, Ill., Dec. 18, 2014 /PRNewswire/ -- Astellas US LLC today announced that the Company's global President and CEO Yoshihiko Hatanaka will present at the 33rd Annual J.P. Morgan...
Read more about Astellas to Present at J.P. Morgan Healthcare Conference
NORTHBROOK, Ill., Nov. 3, 2014 /PRNewswire/ -- Astellas announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to isavuconazole for the treatment of...
SAN FRANCISCO, CA and NORTHBROOK, IL – October 30, 2014 – Medivation Inc. (NASDAQ: MDVN) and Astellas today announced plans to initiate a global Phase 3 clinical trial that will evaluate the...
Company is Exclusive Healthcare Sponsor of USA Eagles vs. New Zealand All Blacks Rugby Match at Soldier Field on Nov. 1 NORTHBROOK, Ill., Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., in...
NORTHBROOK, Ill., Oct. 8, 2014 /PRNewswire/ -- Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3...
Read more about Astellas Presents New Findings For Isavuconazole In Mucormycosis At IDWeek
NORTHBROOK, Ill., Oct. 2, 2014 /PRNewswire/ -- Astellas, a pharmaceutical company based in Northbrook, Ill., launched a new benefits program today to provide support for its almost 3,000 US-based...
Follow U.S. news
